NEWS2 versus shock status to stratify antibiotic urgency in patients with suspected sepsis: a retrospective, multicentre cohort study.
Summary
In 99,667 encounters across nine hospitals, each additional hour to antibiotic administration was associated with higher mortality in patients with shock and in those with NEWS2+ scores of at least 7. Importantly, high NEWS2 identified many non-shock patients in whom delays were also associated with mortality, whereas no such association was observed at lower NEWS2 scores.
Key Findings
- The final cohort included 99,667 encounters from 71,593 patients across nine hospitals, including 4,867 encounters with shock.
- Each additional hour of antibiotic delay was associated with mortality in shock encounters (adjusted odds ratio 1.15) and in encounters with NEWS2+ of at least 7 (adjusted odds ratio 1.07).
- Among patients without shock, 22,902 of 26,551 encounters with NEWS2+ of at least 7 showed a mortality-associated antibiotic delay, while lower NEWS2 categories did not.
Clinical Implications
Emergency and hospital protocols could consider incorporating NEWS2, particularly a score of 7 or higher, into antibiotic-timing pathways rather than relying exclusively on shock status. Implementation should be accompanied by antimicrobial stewardship and prospective evaluation to avoid unnecessary antibiotic exposure in patients without bacterial infection.
Why It Matters
This study directly challenges a shock-only framework for determining antibiotic urgency. It provides large-scale, clinically actionable evidence that a validated early-warning score may identify high-risk non-shock patients who also require rapid antibiotic treatment.
Limitations
- The retrospective design can identify associations but cannot prove that shortening antibiotic delays would causally reduce mortality.
- The cohort came from one US health-care system and excluded several patient groups, which may limit generalizability to other settings and populations.
Future Directions
Prospective implementation studies should test NEWS2-guided antibiotic pathways, evaluate effects on mortality and antibiotic overuse, and compare NEWS2 with other early-warning and sepsis-screening systems across diverse hospitals.
Study Information
- Study Type
- Cohort
- Research Domain
- Treatment
- Evidence Level
- III - Large multicentre retrospective cohort evidence with multivariable adjustment, but without randomization or prospective intervention.
- Study Design
- OTHER